15.46

4.07% -0.655

Pre-market: 15.11 -0.345 -2.23%

Edesa Biotech Inc (EDSA)

Overview News Price History Financials Discussions Forecast Stock Split

Edesa Biotech Inc stock is traded at $15.46, with a volume of 296.27K. It is down -4.07% in the last 24 hours and up +151.71% over the past month. Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Previous Close:

$16.11

Open:

$16.09

24h Volume:

296.27K

Relative Volume:

0.07

Market Cap:

$137.33M

Revenue:

Net Income/Loss:

$-7.82M

P/E Ratio:

-13.48

EPS:

-1.1465

Net Cash Flow:

$-8.00M

1W Performance:

+8.38%

1M Performance:

+151.71%

6M Performance:

+814.50%

1Y Performance:

+543.96%

1-Day Range:

$15.45

$16.50

1-Week Range:

$13.65

$20.32

52-Week Range:

$0.72

$20.32

Edesa Biotech Inc Stock (EDSA) Company Profile

Name

Edesa Biotech Inc

Sector

Healthcare (1106)

Industry

Biotechnology (615)

Phone

(905) 475-1234

Address

100 SPY COURT, MARKHAM, ON

Employee

Twitter

@EdesaBiotech

Next Earnings Date

2026-05-13

Latest SEC Filings

EDSA's Discussions on Twitter

Compare EDSA vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EDSA Edesa Biotech Inc	15.46	137.33M	0	-7.82M	-8.00M	-1.1465
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Edesa Biotech Inc Stock (EDSA) Latest News

May 05, 2026

Edesa Biotech's Market Cap Up US$44m Following Year Of Insider Stock Buying - simplywall.st

May 05, 2026

May 01, 2026

Edesa Biotech (EDSA) CEO awarded 1,159 RSUs and reports updated share holdings - Stock Titan

May 01, 2026

Apr 30, 2026

Edesa Biotech, Inc. Common Shares (EDSA) Stock Price Today & Analysis - Gotrade

Apr 30, 2026

Apr 28, 2026

Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Decreases By 32.5% - MarketBeat

Apr 28, 2026

EDSA - Finviz

Apr 28, 2026

Apr 27, 2026

Edesa Biotech reports FQ1 net loss of $2.2 million - MSN

Apr 27, 2026

EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits

Apr 27, 2026

Edesa Biotech Stock Soars 54%: What’s Driving the ARDS Drug Rally Now - TechStock²

Apr 27, 2026

Edesa (EDSA) Stock: Should You Take Exposure (Investors Pile In) 2026-04-27Community Pattern Alerts - Newser

Apr 27, 2026

Apr 24, 2026

EDSA Should I Buy - Intellectia AI

Apr 24, 2026

Apr 23, 2026

Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock Buying - Yahoo Finance

Apr 23, 2026

Apr 22, 2026

EDSA Edesa Biotech Inc. Common Shares posts narrower Q1 2026 loss than consensus forecasts, shares gain on upbeat investor sentiment.Cost Structure - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 21, 2026

Edesa Biotech Schedules Phase 2 Vitiligo Study for Mid-2026 - HarianBasis.co

Apr 21, 2026

Apr 20, 2026

Edesa (EDSA) Stock Insider Buying (Breakout Watch) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment - Yahoo Finance

Apr 20, 2026

Apr 16, 2026

Is Edesa (EDSA) Stock a Growth Stock? (Recovers) 2026-04-16MA Crossover - Cổng thông tin điện tử tỉnh Lào Cai

Apr 16, 2026

Apr 15, 2026

Edesa (EDSA) Stock Real-Time Quote (In Focus) 2026-04-15Trending Stock Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 15, 2026

Apr 13, 2026

Aug PreEarnings: Can Edesa Biotech Inc sustain earnings growth2026 PreEarnings & Consistent Growth Stock Picks - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Edesa Biotech (EDSA) CEO receives 2,578-share restricted stock grant - Stock Titan

Apr 10, 2026

Apr 06, 2026

Aug Opening: Will Edesa Biotech Inc announce a stock splitDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Apr 06, 2026

Jobs Data: Is Edesa Biotech Inc still a buy after recent gains2026 Big Picture & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Apr 06, 2026

Apr 05, 2026

Edesa Biotech (NASDAQ:EDSA) Rating Increased to Hold at Wall Street Zen - MarketBeat

Apr 05, 2026

Apr 03, 2026

Edesa Biotech (NASDAQ: EDSA) 2026 proxy seeks equity plan boost and director votes - Stock Titan

Apr 03, 2026

Apr 02, 2026